This suite of advocacy briefs was developed for Member States to explain how antimicrobial resistance (AMR) affects health in different contexts and calls for action across sectors and society to mitigate the impact of AMR. They show the cross-cutting challenges posed by this global health threat, sharing achievements as well as lessons learned.

Controlling AMR and preserving antimicrobial medicines for their appropriate use requires everyone’s commitment – from professionals to patients, from politicians to the public, from civil society to the private sector.

AMR occurs when bacteria, parasites, viruses and fungi become resistant to antimicrobial medicines that are used to treat the infections they cause. As a result of AMR, antibiotics and other antimicrobial medicines become ineffective and infections become increasingly difficult – or even impossible – to treat.